Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer

Y Tang, G Qiao, E Xu, Y Xuan, M Liao… - OncoTargets and …, 2017 - Taylor & Francis
Despite advances in the management of non-small cell lung cancer, it remains to be the
leading cause of cancer-related deaths worldwide primarily because of diagnosis at a late …

Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer

Y Tang, G Qiao, E Xu, Y Xuan… - OncoTargets and …, 2017 - pubmed.ncbi.nlm.nih.gov
Despite advances in the management of non-small cell lung cancer, it remains to be the
leading cause of cancer-related deaths worldwide primarily because of diagnosis at a late …

[PDF][PDF] Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer

Y Tang - OncoTargets and Therapy, 2017 - scienceopen.com
Despite advances in the management of non-small cell lung cancer, it remains to be the
leading cause of cancer-related deaths worldwide primarily because of diagnosis at a late …

[PDF][PDF] Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer

Y Tang - OncoTargets and Therapy, 2017 - core.ac.uk
Despite advances in the management of non-small cell lung cancer, it remains to be the
leading cause of cancer-related deaths worldwide primarily because of diagnosis at a late …

Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer.

Y Tang, G Qiao, E Xu, Y Xuan, M Liao… - Oncotargets and …, 2017 - europepmc.org
Despite advances in the management of non-small cell lung cancer, it remains to be the
leading cause of cancer-related deaths worldwide primarily because of diagnosis at a late …

Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer

Y Tang, G Qiao, G Yin, E Xu, Y Xuan, M Liao - OncoTargets and Therapy, 2017 - elibrary.ru
Despite advances in the management of non-small cell lung cancer, it remains to be the
leading cause of cancer-related deaths worldwide primarily because of diagnosis at a late …

Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer

Y Tang, G Qiao, E Xu, Y Xuan, M Liao… - OncoTargets and …, 2017 - search.proquest.com
Despite advances in the management of non-small cell lung cancer, it remains to be the
leading cause of cancer-related deaths worldwide primarily because of diagnosis at a late …

[PDF][PDF] Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer

Y Tang - OncoTargets and Therapy, 2017 - pdfs.semanticscholar.org
Despite advances in the management of non-small cell lung cancer, it remains to be the
leading cause of cancer-related deaths worldwide primarily because of diagnosis at a late …

[HTML][HTML] Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer

Y Tang, G Qiao, E Xu, Y Xuan, M Liao… - OncoTargets and …, 2017 - ncbi.nlm.nih.gov
Despite advances in the management of non-small cell lung cancer, it remains to be the
leading cause of cancer-related deaths worldwide primarily because of diagnosis at a late …

Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer

Y Tang, G Qiao, E Xu, Y Xuan, M Liao… - OncoTargets and …, 2017 - go.gale.com
Despite advances in the management of non-small cell lung cancer, it remains to be the
leading cause of cancer-related deaths worldwide primarily because of diagnosis at a late …